Weatherman Elizabeth H insider trades
Weatherman Elizabeth H has filed 54 Form 4s with the SEC that we hold, for NVRO (Director), SILK (Director), VAPO (Director) and Insulet Corp (PODD) (Director), among 5 companies in all. Across all of them we count 6 purchases worth $2.9M and 9 sales worth $5.3M reported on Form 4. In the last 12 months: 1 purchase ($497.5K) and 0 sales ($0). The largest single trade was a sale of 56,355 shares of SILK worth $3.1M, dated 2023-01-17. The first filing on our record is dated 2021-07-02 and the latest 2026-06-08.
NVRO
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-11-22 | P, purchase reported on Form 4 | 10,703 | $917.7K | 2021-11-22 |
| 2021-11-22 | P, purchase reported on Form 4 | 9,297 | $788.9K | 2021-11-22 |
SILK
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-07-08 | S, sale reported on Form 4 | 10,000 | $419.1K | 2022-07-11 |
| 2022-07-21 | S, sale reported on Form 4 | 5,000 | $209.5K | 2022-07-25 |
| 2022-08-08 | S, sale reported on Form 4 | 8,645 | $431.5K | 2022-08-09 |
| 2022-08-15 | S, sale reported on Form 4 | 5,000 | $236.2K | 2022-08-17 |
| 2022-09-15 | S, sale reported on Form 4 | 5,000 | $212.2K | 2022-09-19 |
| 2023-01-17 | S, sale reported on Form 4 | 56,355 | $3.1M | 2023-01-19 |
| 2023-02-15 | S, sale reported on Form 4 | 5,000 | $249.3K | 2023-02-17 |
| 2023-03-15 | S, sale reported on Form 4 | 5,000 | $209.5K | 2023-03-17 |
| 2023-04-17 | S, sale reported on Form 4 | 5,000 | $209.5K | 2023-04-19 |
VAPO
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-12-02 | P, purchase reported on Form 4 | 89,229 | $134.7K | 2022-12-06 |
| 2022-12-05 | P, purchase reported on Form 4 | 10,423 | $16.3K | 2022-12-07 |
| 2023-02-10 | P, purchase reported on Form 4 | 476,190 | $500.0K | 2023-02-14 |
Insulet Corp (PODD)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-06-03 | P, purchase reported on Form 4 | 3,450 | $497.5K | 2026-06-03 |
Royalty Pharma plc (RPRX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1188681) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms